Inactive

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0068 for an unrestrictive procurement for Anti-Interleukin Monoclonal Antibodies for As... PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0068 for an unrestrictive procurement for Anti-Interleukin Monoclonal Antibodies for Asthma, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the antibodies will be supplied and have a unique NDC number. Solicitation #36E79720R0068 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 16, 2020, with a tentative closing date of September 30, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to: Christopher.Carthron@va.gov. The estimated annual requirements are as follows: ITEM Packages DESCRIPTION Dosing Doses/Year 1a 1 MEPOLIZUMAB 100MG/VIL INJ 100mg Q 4 weeks 13 1b 1 MEPOLIZUMAB 100MG/ML,AUTO INJCT 100mg Q 4 weeks 13 1c 1 MEPOLIZUMAB 100MG/ML,SYRINGE 100mg Q 4 weeks 13 OR OR OR OR OR 2a 1 DUPILUMAB 150MG/ML INJ,SYR,2ML 2 SYRINGES PER PACK 400-600mg loading dose then 200mg or 300mg every other week 13 packs of 2, or 26 syringes 2b 1 DUPILUMAB 200MG/1.14ML INJ,SYR 2 SYRINGE PER PCK 400-600mg loading dose then 200mg or 300mg every other week 26 OR OR OR OR OR 3a 1 BENRALIZUMAB 30MG/ML INJ,SYR,1ML 30mg Q 4 weeks x 3 doses then Q 8 weeks 6.5 3b 1 BENRALIZUMAB 30MG/ML INJ,PEN,1ML 30mg Q 4 weeks x 3 doses then Q 8 weeks 6.5 Agency Number of Patients For Respiratory Use Only VA 3,880 DoD 552 BOP 18 IHS 200 Total Estimated Patients Annually 4,650

Inactive

PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0068 for an unrestrictive procurement for Anti-Interleukin Monoclonal Antibodies for As... PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0068 for an unrestrictive procurement for Anti-Interleukin Monoclonal Antibodies for Asthma, for the Department of Veterans Affairs (VA), Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s and DOD s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the antibodies will be supplied and have a unique NDC number. Solicitation #36E79720R0068 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about September 16, 2020, with a tentative closing date of September 30, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to: Christopher.Carthron@va.gov. The estimated annual requirements are as follows: ITEM Packages DESCRIPTION Dosing Doses/Year 1a 1 MEPOLIZUMAB 100MG/VIL INJ 100mg Q 4 weeks 13 1b 1 MEPOLIZUMAB 100MG/ML,AUTO INJCT 100mg Q 4 weeks 13 1c 1 MEPOLIZUMAB 100MG/ML,SYRINGE 100mg Q 4 weeks 13 OR OR OR OR OR 2a 1 DUPILUMAB 150MG/ML INJ,SYR,2ML 2 SYRINGES PER PACK 400-600mg loading dose then 200mg or 300mg every other week 13 packs of 2, or 26 syringes 2b 1 DUPILUMAB 200MG/1.14ML INJ,SYR 2 SYRINGE PER PCK 400-600mg loading dose then 200mg or 300mg every other week 26 OR OR OR OR OR 3a 1 BENRALIZUMAB 30MG/ML INJ,SYR,1ML 30mg Q 4 weeks x 3 doses then Q 8 weeks 6.5 3b 1 BENRALIZUMAB 30MG/ML INJ,PEN,1ML 30mg Q 4 weeks x 3 doses then Q 8 weeks 6.5 Agency Number of Patients For Respiratory Use Only VA 3,880 DoD 552 BOP 18 IHS 200 Total Estimated Patients Annually 4,650